|
1
|
Hundal R and Shaffer EA: Gallbladder
cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109.
2014.PubMed/NCBI
|
|
2
|
Lazcano-Ponce EC, Miquel JF, Muñoz N,
Herrero R, Ferrecio C, Wistuba II, de Ruiz Alonso P, Aristi Urista
G and Nervi F: Epidemiology and molecular pathology of gallbladder
cancer. CA Cancer J Clin. 51:349–364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaushik SP: Current perspectives in
gallbladder carcinoma. J Gastroenterol Hepatol. 16:848–854. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gore RM and Shelhamer RP: Biliary tract
neoplasms: Diagnosis and staging. Cancer Imaging. 7:S15–S23. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carriaga MT and Henson DE: Liver,
gallbladder, extrahepatic bile ducts and pancreas. Cancer. 75(Suppl
1): S171–S190. 1995. View Article : Google Scholar
|
|
6
|
Wernberg JA and Lucarelli DD: Gallbladder
cancer. Surg Clin North Am. 94:343–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mastoraki A, Papanikolaou IS,
Konstandiadou I, Sakorafas G and Safioleas M: Facing the challenge
of treating gallbladder carcinoma. Review of the literature.
Hepatogastroenterology. 57:215–219. 2010.PubMed/NCBI
|
|
8
|
Tassi E, Braga M, Longhi R, Gavazzi F,
Parmiani G, Di Carlo V and Protti MP: Non-redundant role for IL-12
and IL-27 in modulating Th2 polarization of carcinoembryonic
antigen specific CD4 T cells from pancreatic cancer patients. PloS
One. 4:e72342009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang JF, Hua R, Liu DJ, Liu W, Huo YM and
Sun YW: Effect of CD74 on the prognosis of patients with resectable
pancreatic cancer. Hepatobiliary Pancreat Dis Int. 13:81–86. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kindt N, Lechien JR, Nonclercq D, Laurent
G and Saussez S: Involvement of CD74 in head and neck squamous cell
carcinomas. J Cancer Res Clin Oncol. 140:937–947. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Greenwood C, Metodieva G, Al-Janabi K,
Lausen B, Alldridge L, Leng L, Bucala R, Fernandez N and Metodiev
MV: Stat1 and CD74 overexpression is co-dependent and linked to
increased invasion and lymph node metastasis in triple-negative
breast cancer. J Proteomics. 75:3031–3040. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pinheiro C, Longatto-Filho A, Scapulatempo
C, Ferreira L, Martins S, Pellerin L, Rodrigues M, Alves VA,
Schmitt F and Baltazar F: Increased expression of monocarboxylate
transporters 1, 2 and 4 in colorectal carcinomas. Virchows Arch.
452:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Liu W, Qu Q, Hong T, Xu X, Li B,
Wang Y and He X: Clinical assessment using TNM staging for 151
patients with gallbladder carcinoma. Chinese Journal of
Hepatobiliary Surgery. 20:507–510. 2014.(In Chinese and
English).
|
|
15
|
Reddy SK and Clary BM: Surgical management
of gallbladder cancer. Surg Oncol Clin N Am. 18:307–324. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stinton LM and Shaffer EA: Epidemiology of
gallbladder disease: Cholelithiasis and cancer. Gut Liver.
6:172–187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nagata S, Jin YF, Yoshizato K, Nagata S,
Jin YF, Yoshizato K, Tomoeda M, Song M, Iizuka N, Kitamura M,
Takahashi H, Eguchi H, Ohigashi H, et al: CD74 is a novel
prognostic factor for patients with pancreatic cancer receiving
multimodal therapy. Ann Surg Oncol. 16:2531–2538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roche PA and Cresswell P: Invariant chain
association with HLA-DR molecules inhibits immunogenic peptide
binding. Nature. 345:615–618. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hippo Y, Yashiro M, Ishii M, Taniguchi H,
Tsutsumi S, Hirakawa K, Kodama T and Aburatani H: Differential gene
expression profiles of scirrhous gastric cancer cells with high
metastatic potential to peritoneum or lymph nodes. Cancer Res.
61:889–895. 2001.PubMed/NCBI
|
|
20
|
Jiang Z, Xu M, Savas L, LeClair P and
Banner BF: Invariant chain expression in colon neoplasms. Virchows
Arch. 435:32–36. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu M, Qiu G, Jiang Z, von Hofe E and
Humphreys RE: Genetic modulation of tumor antigen presentation.
Trends Biotechnol. 18:167–172. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Griffiths GL, Mattes MJ, Stein R, Govindan
SV, Horak ID, Hansen HJ and Goldenberg DM: Cure of SCID mice
bearing human B-lymphoma xenografts by an anti-CD74
antibody-anthracycline drug conjugate. Clin Cancer Res.
9:6567–6571. 2003.PubMed/NCBI
|
|
23
|
Burton JD, Ely S, Reddy PK, Stein R, Gold
DV, Cardillo TM and Goldenberg DM: CD74 is expressed by multiple
myeloma and is a promising target for therapy. Clin Cancer Res.
10:6606–6611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ioachim HL, Pambuccian SE, Hekimgil M,
Giancotti FR and Dorsett BH: Lymphoid monoclonal antibodies
reactive with lung tumors. Diagnostic applications. Am J Surg
Pathol. 20:64–71. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lazova R, Moynes R, May D and Scott G:
LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from
malignant fibrous histiocytoma. Cancer. 79:2115–2124. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Young AN, Amin MB, Moreno CS, Lim SD,
Cohen C, Petros JA, Marshall FF and Neish AS: Expression profiling
of renal epithelial neoplasms: A method for tumor classification
and discovery of diagnostic molecular markers. Am J Pathol.
158:1639–1651. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sanchez-Niño MD, Sanz AB, Ruiz-Andres O,
Poveda J, Izquierdo MC, Selgas R, Egido J and Ortiz A: MIF, CD74
and other partners in kidney disease: Tales of a promiscuous
couple. Cytokine Growth Factor Rev. 24:23–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Beswick EJ, Pinchuk IV, Suarez G, Sierra
JC and Reyes VE: Helicobacter pylori CagA-dependent macrophage
migration inhibitory factor produced by gastric epithelial cells
binds to CD74 and stimulates procarcinogenic events. J Immunol.
176:6794–6801. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jung H, Seong HA and Ha H: Critical role
of cysteine residue 81 of macrophage migration inhibitory factor
(MIF) in MIF-induced inhibition of p53 activity. J Biol Chem.
283:20383–20396. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maharshak N, Cohen S, Lantner F, Hart G,
Leng L, Bucala R and Shachar I: CD74 is a survival receptor on
colon epithelial cells. World J Gastroenterol. 16:3258–3266. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Beswick EJ and Reyes VE: Macrophage
migration inhibitory factor and interleukin-8 produced by gastric
epithelial cells during Helicobacter pylori exposure induce
expression and activation of the epidermal growth factor receptor.
Infect Immun. 76:3233–3240. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Itoh Y, Joh T, Tanida S, Sasaki M, Kataoka
H, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, et al: IL-8
promotes cell proliferation and migration through
metalloproteinase-cleavage proHB-EGF in human colon carcinoma
cells. Cytokine. 29:275–282. 2005.PubMed/NCBI
|
